The Discounted Cash Flow (DCF) valuation of AnaptysBio Inc (ANAB) is (506.48) USD. With the latest stock price at 48.23 USD, the upside of AnaptysBio Inc based on DCF is -1150.1%.
Based on the latest price of 48.23 USD and our DCF valuation, AnaptysBio Inc (ANAB) is a sell. selling AnaptysBio stocks now will result in a potential gain of 1150.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.6% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,277.34) - (323.61) | (506.48) |
| Upside | -2748.4% - -771.0% | -1150.1% |